Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
38,175,896
-
Shares change
-
+704,898
-
Total reported value, excl. options
-
$523,888,375
-
Value change
-
-$18,520,051
-
Put/Call ratio
-
160%
-
Number of buys
-
71
-
Number of sells
-
-61
-
Price
-
$13.72
Significant Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q2 2016
176 filings reported holding CLVSQ - CLOVIS ONCOLOGY INC - COM as of Q2 2016.
CLOVIS ONCOLOGY INC - COM (CLVSQ) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38,175,896 shares
.
Largest 10 shareholders include Palo Alto Investors, LLC (3,804,088 shares), Redmile Group, LLC (3,097,850 shares), Consonance Capital Management LP (2,936,487 shares), HealthCor Management, L.P. (2,650,000 shares), VANGUARD GROUP INC (2,405,468 shares), PointState Capital LP (2,228,524 shares), Partner Fund Management, L.P. (1,986,582 shares), GOLDMAN SACHS GROUP INC (1,750,327 shares), STATE STREET CORP (1,635,355 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1,520,794 shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.